Cita APA

Zheng, Y., Yu, T., Mackey, R. H., Gayle, J. A., Wassel, C. L., Phatak, H., & Kim, R. (2021). Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy. Clinicoecon Outcomes Res.

Citación estilo Chicago

Zheng, Ying, Ting Yu, Rachel H. Mackey, Julie A. Gayle, Christina L. Wassel, Hemant Phatak, y Ruth Kim. "Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients With Metastatic Merkel Cell Carcinoma Treated With Immune Checkpoint Inhibitors Vs Chemotherapy." Clinicoecon Outcomes Res 2021.

Cita MLA

Zheng, Ying, et al. "Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients With Metastatic Merkel Cell Carcinoma Treated With Immune Checkpoint Inhibitors Vs Chemotherapy." Clinicoecon Outcomes Res 2021.